Your income portfolio needs to have low-risk and stable investments to reduce volatility and increase income stability. Enterprise offers both strong income and capital appreciation. This company is one of the rarest types of MLPs, one that works for unitholders, not against them.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2024 after the markets close on Thursday, February 27, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, February 27, 2025 5:00.

Downgrade MCHP to hold due to persistent revenue declines, inventory overhang, and deteriorating margins, with no immediate turnaround in sight. 3Q25 results showed a 42% y/y revenue decline, with gross margin compressing to 54.7% and EBIT margin dropping to 15.7%. Inventory levels remain critically high, impacting revenue growth and margins, with distributors still working through existing stock.

Total Q4 gold production of GOLD is 1,080,000 ounces, up around 2.5% year over year.

Last year was a transitional period for W. P. Carey (WPC 2.78%).

Qorvo shifts focus to premium 5G products, abandoning mid-tier Android markets, impacting revenue but improving long-term margins and growth prospects. Management projects single-digit decline in ACG revenue for fiscal '26, with 10-12% growth in CSG and HPA segments. December quarter results exceeded guidance, with $916 million revenue, $1.61 EPS, and strong cash flow, despite challenges in mobile and automotive markets.

PG&E Corp on Thursday raised its adjusted core earnings forecast for 2025, as the power company benefits from lower operating expenses and higher electricity rates.

Right now, two technology stocks stand out for their rebound to kick off 2025. Shares are appreciating strongly after getting crushed in the final quarter of 2024.

REHOVOT, Israel, Feb. 13, 2025 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights: Record Quarterly revenue of $194.8 million, a 9% QoQ increase, exceeding the Company guidance and up 45% YoY.

Singapore, Feb. 13, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”) is pleased to announce the appointment of Mark Wendou Niu as Group Chief Strategy Officer. In this strategic role, Mark will lead YY Group's fundraising efforts, investor relations, and digital and AI transformation, furthering the Group's vision to become a global leader in on-demand staffing and integrated facility management solutions.

TROY, Mich., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced fourth-quarter and full-year 2024 earnings.

Together with Blue Sourberry and Altitude Lemon Lime, Deep Space Propulsion Continues to Pioneer the High-Potency Cannabis Beverage Category with its Expanded Portfolio of Innovative Flavours SMITHS FALLS, ON , Feb. 13, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today the expansion of its Deep Space Propulsion beverage lineup with two new flavours: Rocket Root Beer and Charged Cream Soda. Proudly developed in Canada, these innovative takes on classic flavours join Blue Sourberry and Altitude Lemon Lime, …

Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout expected later this month Novel 'next generation' selective MC4R long-acting peptide and an oral small molecule Multiple clinical trials targeted in calendar year 2025 For the treatment of general obesity, weight loss management, and rare MC4R pathway diseases, including hypothalamic obesity Phase 2 clinical study of PL8177 oral formulation for the treatment of ulcerative colitis Topline data readout expected later this quarter Teleconference and Webcast to be held on February 13, 2025, at 11:00 AM ET CRANBURY, N.J. , Feb. …

MADISON, N.J. , Feb. 13, 2025 /PRNewswire/ -- Anywhere Real Estate Inc. (NYSE: HOUS) ("Anywhere" or the "Company"), a global leader in residential real estate services, today reported financial results for the fourth quarter and full year ended December 31, 2024.

RESTON, Va. , Feb. 13, 2025 /PRNewswire/ -- V2X Inc. (NYSE: VVX) has been awarded a position on the General Services Administration's (GSA) One Acquisition Solution for Integrated Services Plus (OASIS+) contract across all eight domains, solidifying its role as a leading provider of integrated mission solutions for the U.S. Government.

Pampa Energia is Argentina's largest private energy conglomerate with a diversified portfolio in LNG, electric power, and petrochemical products, holding a strong market position. The company has solid fundamentals, including decreasing net debt, strong liquidity, and growing sales in both Power and Oil & Gas segments. Pampa's valuation remains attractive despite recent gains, trading at significant discounts compared to industry averages, with a target price suggesting further upside potential.

Shares of Oklo Inc. (NYSE: OKLO) have soared 137% over the past month, gaining traction as a strong bet on nuclear energy's role in powering AI-driven infrastructure.

IBEX Limited receives a Strong Buy rating due to profitable growth, selective market choices, and productivity improvements, with a one-year price target of $30.66. The company offers end-to-end customer engagement solutions, leveraging AI technology and boasting high client retention rates and significant offshore revenue contributions. Q2-fiscal-2025 results show good revenue growth, increased adjusted EBITDA, and a significant reduction in shares outstanding, enhancing future net income and earnings.

T. Rowe Price's Anthony Wang talks about what he needs to keep his Science & Technology Fund outperforming.

Returned a record $469 million to shareholders in 2024 MCLEAN, Va. , Feb. 13, 2025 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq:IRDM) ("Iridium") today reported financial results for the fourth quarter and full-year 2024 and issued its full-year 2025 guidance.